Nucleoredoxin, glutaredoxin, and thioredoxin differentially regulate NF-κB, AP-1, and CREB activation in HEK293 cells

Biochemical and Biophysical Research Communications

Volumn 274, Issue 1, 2000, Pages 177-182

  Hirota, Kiichi ^a   Matsui, Minoru ^b   Murata, Miyahiko ^b   Takashima, Yuichiro ^b   Cheng, Fen Shi ^b   Itoh, Tatsuya ^a   Fukuda, Kazuhiko ^a   Junji, Yodoi ^b  

^a KYOTO UNIVERSITY HOSPITAL   (Japan)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; FORSKOLIN; GLUTAREDOXIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; NUCLEOREDOXIN; OXIDOREDUCTASE; PHORBOL 13 ACETATE 12 MYRISTATE; THIOREDOXIN; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENZYME REGULATION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN LOCALIZATION; TRANSCRIPTION REGULATION;

EID: 0033913980     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.2000.3106     Document Type: Article

References (26)

1. Pahl H. L., Baeuerle P. A. Oxygen and the control of gene expression. BioEssays. 16:1994;497-502.
2. Nakamura H., Nakamura K., Yodoi J. Redox regulation of cellular activation. Annu. Rev. Immunol. 15:1997;351-369.
3. Holmgren A. Thioredoxin and glutaredoxin systems. J. Biol. Chem. 264:1989;13963-13966.
4. Kurooka H., Kato K., Minoguchi S., Takahashi Y., Ikeda J., Habu S., Osawa N., Buchberg A. M., Moriwaki K., Shisa H., Honjo T. Cloning and characterization of the nucleoredoxin gene that encodes a novel nuclear protein related to thioredoxin. Genomics. 39:1997;331-339.
5. Yoshitake S., Nanri H., Fernando M. R., Minakami S. Possible differences in the regenerative roles played by thioltransferase and thioredoxin for oxidatively damaged proteins. J. Biochem. Tokyo. 116:1994;42-46.
6. Makino Y., Okamoto K., Yoshikawa N., Aoshima M., Hirota K., Yodoi J., Umesono K., Makino I., Tanaka H. Thioredoxin: A redox-regulating cellular cofactor for glucocorticoid hormone action. Cross-talk between endocrine control of stress response and cellular antioxidant defense system. J. Clin. Invest. 98:1996;2469-2477.
7. Hirota K., Matsui M., Iwata S., Nishiyama A., Mori K., Yodoi J. AP-1 transcriptional activity is regulated by a direct association between thioredoxin and Ref-1. Proc. Natl. Acad. Sci. USA. 94:1997;3633-3638.
8. Hayashi S.-I., Hajiro-Nakanishi K., Makino Y., Eguchi H., Yodoi J., Tanaka H. Functional modulation of estrogen receptor by redox state with reference to thioredoxin as a mediator. Nucleic Acids Res. 25:1997;4035-4040.
9. Makino Y., Yoshikawa N., Okamoto K., Hirota K., Yodoi J., Makino I., Tanaka H. Direct association with thioredoxin allows redox regulation of glucocorticoid receptor function. J. Biol. Chem. 274:1999;3182-3188.
10. Takashima Y., Hirota K., Nakamura H., Nakamura T., Akiyama K., Chen F.-S., Maeda M., Yodoi J. Differential expression of glutaredoxin and thioredoxin during monocytic differentiation. Immunol. Lett. 68:1999;397-401.
11. Shinkura R., Kitada K., Matsuda F., Tashiro K., Ikuta K., Suzuki M., Kogishi K., Serikawa T., Honjo T. Alymphoplasia is caused by a point mutation in the mouse gene encoding NF-κB-inducing kinase. Nature Genetics. 22:1999;74-77.
12. Hirota K., Murata M., Sachi Y., Nakamura H., Takeuchi J., Mori K., Yodoi J. Distinct roles of thioredoxin in the cytoplasm and in the nucleus. A two-step mechanism of redox regulation of transcription factor NF-B. J. Biol. Chem. 274:1999;27891-27897.
13. Schmitz M. L., dos Santos Silva M. A., Baeuerle P. A. Transactivation domain 2 (TA) of p65 NF-B. J. Biol. Chem. 270:1995;15576-15584.
14. 2+-regulated transcription factor phosphorylated by calmodulin-dependent kinases. Science. 252:1991;1427-1430.
15. Han J., Jiang Y., Li Z., Kravchenko V. V., Ulevitch R. J. Activation of the transcription factor MEF2C by the MAP kinase p38 in inflammation. Nature. 386:1997;296-299.
16. Gallegos A., Gasdaska J. R., Taylor C. W., Paine-Murrieta G. D., Goodman D., Gasdaska P. Y., Berggren M., Briehl M. M., Powis G. Transfection with human thioredoxin increase cell proliferation and a dominant-negative mutant thioredoxin reverses the transformed phenotype of human breast cancer cells. Cancer Res. 56:1996;5765-5770.
17. Holmgren A., Åslund F. Glutaredoxin. Methods Enzymol. 252:1995;283-292.
18. Åslund F., Berndt K. D., Holmgren A. Redox potentials of glutaredoxin and other thiol-disulfide oxidoreductases of the thioredoxin superfamily determined by direct protein-protein redox equilibria. J. Biol. Chem. 272:1997;30780-30786.
19. Bae Y. S., Kang S. W., Seo M. S., Baines I. C., Tekle E., Chock P. B., Rhee S. G. Epidermal growth factor (EGF)-induced generation of hydrogen peroxide. J. Biol. Chem. 272:1997;217-221.
20. Mitsui A., Hirakawa T., Yodoi J. Reactive oxygen-reducing and protein-refolding activities of adult T cell leukemia-derived factor/human thioredoxin. Biochem. Biophys. Res. Commun. 186:1992;1220-1226.
21. Kang S. W., Baines I. C., Rhee S. G. Characterization of a mammalian peroxiredoxin that containes one conserved cysteine. J. Biol. Chem. 273:1998;6303-6311.
22. Kang S. W., Chae H. Z., Seo M. S., Kim K., Baines I. C., Rhee S. G. Mammalian peroxiredoxin isoforms can reduce hydrogen peroxide generated in response to growth factors and tumor necrosis factor-α J. Biol. Chem. 273:1998;6297-6302.
23. Ema M., Hirota K., Mimura J., Abe H., Yodoi J., Sogawa K., Poellinger L., Fujii-Kuriyama Y. Molecular mechanisms of transcription activation by HLF and HIF1alpha in response to hypoxia: Their stabilization and redox signal-induced interaction with CBP/p300. EMBO J. 18:1999;1905-1914.
24. Watson J. A., Rumsby M. G., Wolowacz R. G. Phage display identifies thioredoxin and superoxide dismutase as novel protein kinase C-interacting proteins: Thioredoxin inhibits protein kinase C-mediated phosphorylation of histone. Biochem. J. 343:1999;301-305.
25. Saito M., Nishitoh H., Fujii M., Takeda K., Tobiume K., Miyazono K., Ichijo H. Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (Ask) 1. EMBO J. 17:1998;2596-2606.
26. Takeuchi J., Hirota K., Itoh T., Shinkura R., Kitada K., Yodoi J., Namba T., Fukuda K. Thioredoxin inhibits tumor necrosis factor- or interleukin-1-induced NF-κB activation at the level upstream of NF-κB-inducing kinase. Antiox. Redox Signal. 2:2000;83-92.